BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12750159)

  • 21. Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma.
    Lamant L; Gascoyne RD; Duplantier MM; Armstrong F; Raghab A; Chhanabhai M; Rajcan-Separovic E; Raghab J; Delsol G; Espinos E
    Genes Chromosomes Cancer; 2003 Aug; 37(4):427-32. PubMed ID: 12800156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation.
    Adam P; Katzenberger T; Seeberger H; Gattenlöhner S; Wolf J; Steinlein C; Schmid M; Müller-Hermelink HK; Ott G
    Am J Surg Pathol; 2003 Nov; 27(11):1473-6. PubMed ID: 14576483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells.
    Maes B; Vanhentenrijk V; Wlodarska I; Cools J; Peeters B; Marynen P; de Wolf-Peeters C
    Am J Pathol; 2001 Jun; 158(6):2185-93. PubMed ID: 11395396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
    Werner MT; Zhao C; Zhang Q; Wasik MA
    Blood; 2017 Feb; 129(7):823-831. PubMed ID: 27879258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity.
    Cussac D; Greenland C; Roche S; Bai RY; Duyster J; Morris SW; Delsol G; Allouche M; Payrastre B
    Blood; 2004 Feb; 103(4):1464-71. PubMed ID: 14563642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.
    Ma Z; Hill DA; Collins MH; Morris SW; Sumegi J; Zhou M; Zuppan C; Bridge JA
    Genes Chromosomes Cancer; 2003 May; 37(1):98-105. PubMed ID: 12661011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common ALK gene rearrangement in Asian CD30+ anaplastic large cell lymphoma: an immunohistochemical and fluorescence in situ hybridisation (FISH) study on paraffin-embedded tissue.
    Tai YC; Kim LH; Peh SC
    Pathology; 2003 Oct; 35(5):436-43. PubMed ID: 14555389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytomorphology and molecular characterization of CLTC-ALK rearrangement in 2 cases of ALK-positive diffuse large B-cell lymphoma with extensive bone marrow involvement].
    Choung HS; Kim HJ; Kim WS; Kim K; Kim SH
    Korean J Lab Med; 2008 Apr; 28(2):89-94. PubMed ID: 18458503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein.
    Ergin M; Denning MF; Izban KF; Amin HM; Martinez RL; Saeed S; Alkan S
    Exp Hematol; 2001 Sep; 29(9):1082-90. PubMed ID: 11532349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma.
    Pulford K; Falini B; Cordell J; Rosenwald A; Ott G; Müller-Hermelink HK; MacLennan KA; Lamant L; Carbone A; Campo E; Mason DY
    Am J Pathol; 1999 Jun; 154(6):1657-63. PubMed ID: 10362790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation.
    Damm-Welk C; Klapper W; Oschlies I; Gesk S; Röttgers S; Bradtke J; Siebert R; Reiter A; Woessmann W
    Br J Haematol; 2009 Aug; 146(3):306-9. PubMed ID: 19545284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins.
    Elenitoba-Johnson KS; Crockett DK; Schumacher JA; Jenson SD; Coffin CM; Rockwood AL; Lim MS
    Proc Natl Acad Sci U S A; 2006 May; 103(19):7402-7. PubMed ID: 16651537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.
    Cerchietti L; Damm-Welk C; Vater I; Klapper W; Harder L; Pott C; Yang SN; Reiter A; Siebert R; Melnick A; Woessmann W
    PLoS One; 2011 Apr; 6(4):e18436. PubMed ID: 21494621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
    Leventaki V; Drakos E; Medeiros LJ; Lim MS; Elenitoba-Johnson KS; Claret FX; Rassidakis GZ
    Blood; 2007 Sep; 110(5):1621-30. PubMed ID: 17416736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYC.
    Moritake H; Shimonodan H; Marutsuka K; Kamimura S; Kojima H; Nunoi H
    Am J Hematol; 2011 Jan; 86(1):75-8. PubMed ID: 21080342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus association and ALK gene expression in anaplastic large-cell lymphoma.
    Agarwal S; Ramanathan U; Naresh KN
    Hum Pathol; 2002 Feb; 33(2):146-52. PubMed ID: 11957137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anaplastic lymphoma kinase gene abnormality and the expression of its fusion protein in primary systemic anaplastic large cell lymphoma].
    Shi YF; Liu CL; Zhou CJ; Gong LP; Dong LN; Li M; Huang X; Gao ZF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):380-6. PubMed ID: 18677384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma.
    Waggott W; Lo YM; Bastard C; Gatter KC; Leroux D; Mason DY; Boultwood J; Wainscoat JS
    Br J Haematol; 1995 Apr; 89(4):905-7. PubMed ID: 7772531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas.
    Gesk S; Gascoyne RD; Schnitzer B; Bakshi N; Janssen D; Klapper W; Martín-Subero JI; Parwaresch R; Siebert R
    Leukemia; 2005 Oct; 19(10):1839-40. PubMed ID: 16107887
    [No Abstract]   [Full Text] [Related]  

  • 40. ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript.
    Wang WY; Gu L; Liu WP; Li GD; Liu HJ; Ma ZG
    Pathol Res Pract; 2011 Sep; 207(9):587-91. PubMed ID: 21855232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.